Evidence map›Paper›PMID 31800580›Full record

Observational studyPloS one2019

Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.

Morgane Rousselet, Marylène Guerlais, Pascal Caillet, Bertrand Le Geay, Damien Mauillon, Patrick Serre, Pierre-Yves Chameau, Yves Bleher, Serge Mounsande, Pascale Jolliet and 1 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Morgane RousseletCentre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, Nantes University Hospital, France.
Marylène GuerlaisCentre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, Nantes University Hospital, France.
Pascal CailletCentre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, Nantes University Hospital, France.ORCID 0000-0001-5667-7887
Bertrand Le GeayDepartment of Prison Psychiatry, Nantes University Hospital, France.
Damien MauillonMedical department of prison, Angers University Hospital, France.
Patrick SerreMedical department of prison, Le Mans HospitalFrance.
Pierre-Yves ChameauMedical department of prison, Laval Hospital, France.
Yves BleherMedical department of prison, La Roche sur Yon Departemental Hospital, Boulevard Stéphane Moreau, France.
Serge MounsandeMedical department of prison, Fontenay-Le-Comte Hospital, France.
Pascale JollietCentre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, Nantes University Hospital, France.
Caroline Victorri-VigneauCentre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, Nantes University Hospital, France.
Université de Tours · FRCentre Hospitalier du Mans · FRLaval Mayenne Technopole · FRNantes Université · FRRoche (France) · FRUniversité d'Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew studies have examined the consumption trajectories of inmates after entry to prison. The aim of this study was to assess the changes in the consumption of psychoactive substance between the period before detention and during incarceration and to characterize the profiles of prisoners with similar consumption trajectories during incarceration. METHODS AND

findingsA multicenter, cross-sectional study was performed in all of the prisons from one region of France. All prisoners incarcerated during their 3rd months, over 18 years old, and with a sufficient level of French fluency to participate in the study were recruited over a period of 12 months. A total of 800 prisoners were recruited. All prisoners were interviewed face-to-face by a trained interviewer. A majority of prisoners had used at least one psychoactive substance in the weeks prior to incarceration. During incarceration, a substantial reduction in alcohol and illicit drug consumption was observed. The initiation of consumption and an increase in consumption were primarily related to medications. Five different profiles of consumption before incarceration were identified. These profiles all had a high probability of migrating to a similar profile during detention, characterized by less severe consumption of psychoactive substances.

conclusionsBased on their consumption profile prior to incarceration, most prisoners would benefit from a specific medical evaluation as soon as possible following entry into detention. Prison could be an opportunity for reduced consumption and/or the initiation of treatment for the majority of prisoners, despite the pejorative development observed for a minority of prisoners during incarceration.

Indexed as

AdultFranceHumansMaleMiddle AgedPrisonersPrisonsSubstance-Related Disorders

Identifiers

PMID31800580
PMCPMC6892542
OpenAlexW2991917985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.